[Federal Register Volume 88, Number 83 (Monday, May 1, 2023)]
[Notices]
[Page 26569]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-09175]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2023-N-1358]


FDA Science Forum 2023; Public Workshop

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public workshop.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is 
announcing the following public workshop entitled ``FDA Science Forum 
2023.'' The purpose of the public workshop is to inform the public 
about the breadth of research underway at the Agency, and to show how 
cutting-edge science informs FDA's regulatory decision-making to 
protect and promote public health.

DATES: The public workshop will be held on June 13, 2023 (Day 1), from 
9 a.m. to 3:30 p.m. Eastern Time, and June 14, 2023 (Day 2), from 9 
a.m. to 2 p.m. Eastern Time. See the SUPPLEMENTARY INFORMATION section 
for registration date and information.

ADDRESSES: The public workshop will be held via webcast.

FOR FURTHER INFORMATION CONTACT: Rokhsareh Shahidzadeh, Office of 
Scientific Professional Development, Office of the Chief Scientist, 
Office of the Commissioner, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 32, Rm. 2383, Silver Spring, MD 20993, 301-796-
8740, FDASciProDev@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: 

I. Background

    The FDA Science Forum is held biennially to inform the public about 
the groundbreaking science conducted at the Agency, and to show how 
scientific research is used in FDA's regulatory decisions to protect 
and promote public health. Open to the public, industry, academia, 
patient advocates, government agencies, and current and potential 
collaborators, the 2-day event offers an opportunity to hear FDA 
scientific experts and nationally renowned scientists speak on a range 
of topics associated with regulatory science.

II. Topics for Discussion at the Public Workshop

    The theme for the 2023 FDA Science Forum, ``Advancing Regulatory 
Science Through Innovation,'' will highlight areas of FDA research, 
including: (1) improving clinical and postmarket evaluation, (2) tools 
to effectively use big data, (3) product development tools and 
manufacturing, and (4) medical countermeasures (MCMs), infectious 
disease and pathogen reduction technologies.

III. Participating in the Public Workshop

    Registration: To register for the public workshop, please visit the 
following website: https://www.fda.gov/scienceforum.
    Registration is free. Persons interested in attending this public 
workshop must register by June 12, 2023, at 5 p.m. Eastern Time. 
Registrants will receive confirmation when they have been accepted.
    If you need special accommodations due to a disability, please 
contact Rokhsareh Shahidzadeh (see FOR FURTHER INFORMATION CONTACT) no 
later than June 5, 2023, by 5 p.m. Eastern Time.
    Streaming Webcast of the public workshop: This public workshop will 
be webcast. To register, please visit the following website: https://www.fda.gov/scienceforum. Participants interested in viewing via 
webcast must register by June 12, 2023, at 5 p.m. Eastern Time.

    Dated: April 26, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-09175 Filed 4-28-23; 8:45 am]
BILLING CODE 4164-01-P